SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and subsequent revitalization for regenerated skin under the SUPERB brand; and non-invasive muscle toning technology under the Pure Impact VIP brand. It serves plastic surgeons, dermatologists, and other physicians who perform aesthetic treatments on patients. It also provides technical and clinical product support services. The company was incorporated in 2015 and is based in Yokneam Illit, Israel.
Frequently asked questions
What sector does SOFWF (SOFWF) operate in?
SOFWF belongs to the Other sector and operates in the Medical Devices industry.
What is SOFWF (SOFWF) current stock price?
As of the latest data, SOFWF stock price is $9.93, with a previous close of $9.93.
What is SOFWF (SOFWF) current market capitalization?
SOFWF market cap is approximately 361.20 million.
What is SOFWF (SOFWF) Earnings Per Share (EPS)?
The trailing EPS is $0.21.
What is SOFWF (SOFWF) Price-to-Earnings (P/E) ratio?
SOFWF current P/E ratio is 47.29.
What is SOFWF (SOFWF) EBITDA?
SOFWF EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 3.64 million.
Does SOFWF (SOFWF) pay dividends?
No. SOFWF does not pay a dividend.
What is SOFWF (SOFWF) beta (volatility) score?
SOFWF has a beta of 0.710, indicating lower volatility than the overall market.